Beacon Pharmaceuticals PLC (DSE: BEACONPHAR)
Health Care · Pharmaceuticals · BD
Tk102.70
+0.10% today · -7.6% 1Y
Beacon Pharmaceuticals PLC (DSE: BEACONPHAR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $192.63M.
Over the last twelve months the share price has lost 7.6%, trading between 93.20 and 118.20.
Tweenvest scores Beacon Pharmaceuticals PLC across four factors: quality 63/100, value 72/100, growth 82/100, dividend 34/100. Its strongest factor is growth.
BEACONPHAR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $192.63M
- Revenue (TTM)
- $126.93M
- P/E
- 16.28
- EPS
- 6.31
- Dividend yield
- 2.04%
- Beta (5Y)
- -0.09
- 52-week high
- Tk118.20
- 52-week low
- Tk93.20
- Avg volume (3M)
- —
- Shares outstanding
- 231.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Humedix Co., Ltd.KOSDAQ: A200670 | $196.90M | ₩25,650.00 | -0.19% |
| Seikagaku CorporationTSE: 4548 | $195.53M | ¥567.00 | -0.70% |
| Newron Pharmaceuticals S.p.A.SWX: NWRN | $194.03M | CHF7.59 | -6.53% |
| Ha Tay Pharmaceutical JSCHNX: DHT | $193.22M | ₫50,200.00 | 0.00% |
| Korea United Pharm Inc.KOSE: A033270 | $189.84M | ₩17,860.00 | +1.88% |
| BioVersys AGSWX: BIOV | $187.08M | CHF26.40 | -0.38% |
| NGL Fine-Chem LimitedBSE: 524774 | $186.76M | Rs2,925.65 | +0.01% |
| MINAPHARM PharmaceuticalsCASE: MIPH | $186.58M | EGP829.40 | +2.08% |
Figures last refreshed Oct 11, 2026.